Andere Sprachen Bio-Rad Laboratories, Inc.

Aktien

865406

US0905722072

BIO

Markt geschlossen - Nyse Andere Börsenplätze 22:00:01 06.05.2024			% 5 Tage	% 1. Jan.
282 ^USD	+0,76 %		+1,75 %	-12,67 %

29.04.	BIO-RAD LABORATORIES, INC. : Bewertung von RBC Capital Markets zum Kaufen erhalten	ZM
26.04.	Bio-Rad Laboratories, Inc. kündigt Änderungen bei Executive Vice President und President, Life Science Group an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bio-Rad's Management to Participate in Fireside Chat during RBC Capital Markets Global Healthcare Conference	02.05.
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference	01.05.
Bio-Rad Announces Life Science Group Management Changes	29.04.
Bio-Rad Announces Life Science Group Management Changes	26.04.
Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	26.04.
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	18.04.
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	15.04.
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	11.04.
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	11.04.
Bio-Rad Laboratories COO Andrew Last to Retire in September	10.04.
Bio-Rad’s Chief Operating Officer Andrew Last to Retire	10.04.
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	10.04.
North American Morning Briefing : Focus Turns to -2-	04.04.
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25.03.
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	20.03.
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer	20.03.
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as Chief Financial Officer, Effective April 15, 2024	20.03.
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	20.03.
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	29.02.
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Rad Laboratories, Inc.

Aktien

865406

US0905722072

BIO

Andere Sprachen

Filter